S&P 500 7,636.36 −0.48%
Nasdaq 26,253.34 −0.64%
S&P/TSX 35,906.56 −0.60%
Apple 315.34 −0.28%
Nvidia 223.67 −0.91%
Microsoft 491.65 −0.47%
Shopify 175.13 −5.35%
Royal Bank 285.59 −0.91%
CAD/USD 0.7243 −0.21%
CLOSED · 01:35 ET
Market ClerkRecap
Thu Sep 10 · markets closed4 signals on Sep 9217 insider buys this week · $297.2MCIRO short report next: Sep 14The week ahead
LY
INSIDER · BLTE · BELITE BIO, INC · CHIEF EXECUTIVE OFFICER

Lin Yu-Hsin

Every open-market transaction filed under this name, Sep 4 to Sep 8.

Filings
19
0 buys · 19 sells
Bought
open market, at cost
Sold
$19.1M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 8BLTEBELITE BIO, INCChief Executive OfficerSell2,700$198.09$535K
Sep 8BLTEBELITE BIO, INCChief Executive OfficerSell8,752$197.36$1.7M
Sep 8BLTEBELITE BIO, INCChief Executive OfficerSell6,058$196.54$1.2M
Sep 8BLTEBELITE BIO, INCChief Executive OfficerSell6,090$195.62$1.2M
Sep 8BLTEBELITE BIO, INCChief Executive OfficerSell2,400$194.33$466K
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell8,111$193.13$1.6M
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell4,209$192.54$810K
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell11,080$191.15$2.1M
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell600$190.39$114K
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell8,955$189.34$1.7M
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell3,045$188.26$573K
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell6,200$187.25$1.2M
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell7,800$186.32$1.5M
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell4,593$185.34$851K
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell6,252$184.52$1.2M
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell4,955$183.30$908K
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell3,413$182.50$623K
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell2,587$181.24$469K
Sep 4BLTEBELITE BIO, INCChief Executive OfficerSell2,635$180.29$475K

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.